Top Stories News
Top Stories news
-
News UK to change patent laws to attract clinical trials
The UK government intends to take steps to attract drug research and development projects back to the UK. -
News Apposition III clinical trials show low mortality rates
The Stentys Self-Apposing Stent clinical trials show low death rates in patients following severe heart attack. -
News Drug formulation developer Dyax announces board changes
The executive vice president chief operating officer of the company, which specialises in drug formulations for unmet medical needs, is leaving for other opportunities. -
News Rheumatoid arthritis clinical trial to continue
Drug formulation PRTX-100 passed a scheduled interim data safety monitoring committee meeting. -
News OncoMed begins Phase 1 clinical trial of stem cell drug
OMP-52M51 is a therapeutic that targets cancer stem cells. -
News Immune system-enhancing drug could beat colorectal cancer
Tests involving the delivery of an immune system-enhancing drug to patients suffering from colorectal cancer have shown promise. -
News Abbott completes separation into two independent companies
A new independent company called AbbVie has been formed to take forward Abbott's research-based pharmaceuticals business. -
News Saudi Arabia pharma market to reach $4.7bn by 2016
Saudi Arabia is one of the largest pharmaceutical markets in the Middle East and is due to experience steady growth. -
News Novartis names Dr Joerg Reinhardt as new chairman
Dr Joerg Reinhardt will be the new chairman of Novartis, succeeding Dr Daniel Vasella. -
News OvaSciences announced 2012 financial results
OvaSciences enjoyed a strong year with most of its R&D spend coming on CROs for a major new trial. -
News Ligand receives milestone payment in development of RE-021
Development of the clinical candidate RE-021 is being handled by Retrophin, which also has commercialisation rights. -
News Digital Pharma Experience set for Prague
The Digital Pharma Experience takes place in Prague in May. -
News Diagnovus designs assay for DLBCL
Diagnovus' new gene expression assay aims to provide more accurate risk profiles for DLBCL patients. -
News Roche to commercialise Chiasmas Octreolin treatment
Roche has acquired global licencing rights for the acromegaly treatment, which is in phase three trials. -
News Almac and DSM Pharma sharing enzyme expertise
The two firms are collaborating to improve their green performance and enzyme process development. -
News Nerve growth trial goes international
Neurotrophic keratitis patients to get eyedrop treatment. -
News Ulcerative colitis patients get new treatment
New treatment to help mild sufferers of ulcerative colitis. -
News Cancer Commons announces expansion
Cancer research organisation will include six new members. -
News New contract services provided by BioMed
BioMed has launched its new pharmacy management system RxVector. -
News Heart failure treatment gets funding
New diagnostic tests to be developed as a result of funding. -
News Microarray to be used in human identification
Affymetrix and DNA Link team up to consumerise DNA identification technology . -
News Genentech sees positive results from its CLL drug trials
Genentech has seen positive results in Phase III trials of its CLL drug. -
News Vertex sets out goals for 2013
Vertex will continue with its research into cystic fibrosis, hepatitis C and autoimmune diseases this year. -
News Development of sealants will speed up move away from conventional sutures
New innovations in the medical adhesives sector will accelerate the move away from the use of sutures and staples. -
News TetraLogic receives birinapant patent
Japan recognises birinapant innovation. -
News Sectra enters Southeast Asian market
Asia to get new visualisation technology from Sectra. -
News Leading pharmaceutical companies set to merge
BioSante and ANI Pharmaceuticals arrange special meetings for merger. -
News New fund to benefit pancreatic cancer research
US foundation commits £25 million to fighting pancreatic cancer. -
News Avoca Group announces key initiatives for outsourcing consortium
Avoca's outsourcing group has set out its key goals for 2013. -
News Skin substitute trials 'a success'
Patients will no longer have to undergo painful autografting for second-degree burns. -
News BioChemics patents wound healing treatment
BioChemics ventures into wound treating market. -
News Top pharmacists gather for conference
Independent pharmaceutical companies to discuss the changing industry. -
News Anacor director receives science award
Scientific medal goes to Dr Lucy Shapiro of Anacor Pharmaceuticals. -
News Spectrum Pharmaceuticals outlines five-year vision
Spectrum announces new arrival plus its plan for the next five years. -
News Outsourcing market to value $41bn
Device outsourcing set to rise exponentially between now and 2018. -
News Pharmaceutical companies increase outsourcing
Number of pharmaceutical companies using outsourcing increases. -
News South Korea set for global biosimilars leadership
A Frost & Sullivan report has predicted significant growth in the South Korean biosimilars market between now and 2020. -
News Brain tumour investment 'lagging'
Funding for research and treatment of brain tumours is 'lagging behind' other cancers, says a charity. -
News Pfizer Licenses Quinazoline Drug Program
Repligen Corp. has entered into an exclusive worldwide licensing agreement with Pfizer to advance its spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA). -
News Tranzyme, BMS Complete Drug Pact
Tranzyme Pharma has successfully completed its chemistry-based drug discovery collaboration with Bristol-Myers Squibb and has transferred compounds, across multiple drug targets, to BMS for further development. -
News Israeli pharma market 'worth $2.3 billion by 2020'
GlobalData's latest report looks at the prospects for the pharmaceutical industry in Israel. -
News Chinese pharmaceutical market to enjoy 'dramatic' growth
A new report looks at the potential for growth in the Chinese pharmaceutical market. -
News GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique
GSK has formed a partnership with Vodafone to harness innovative mobile technology to help vaccinate more children against common infectious diseases in Africa. -
News Epilepsy drug market to reach nearly $3.7bn by 2016
Decision Resources has published its latest predictions for the epilepsy drug market through 2021. -
News Next Generation Sequencing of GATC Biotech AG Accredited by German DAkkS
GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation -
News Health economics and outcomes research 'increasingly important to pharma'
A new report suggests that more and more pharmaceutical companies are devoting dedicated budgets to health economics and outcomes research. -
News Ranbaxy Begins Atorvastatin Recall
Ranbaxy, Inc., a subsidiary of Indias Ranbaxy Laboratories Ltd., has initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium tablets (10 mg, 20 mg and 40 mg), a generic of Pfizers Lipitor. -
News Schott to expand pharmaceutical packaging manufacturing in Russia
German company Schott has announced plans to increase its production capacity in Russia by more than 50 per cent. -
News Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim
Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim -
News GSK set to increase stake in Indian subsidiary
GSK has offered to increase its stake in GSK Consumer Healthcare in India. -
News AstraZeneca Canada and Pfizer Canada partner with Quebec government
The NEOMED Institute is a new public-private partnership between biopharmaceutical companies and the Quebec government. -
News Number of temperature-sensitive drugs 'set to increase'
A growing number of biopharmaceutical products have cold chain requirements, according to IMARC Group's latest report. -
News Pharma industry to thrive after 2020
A new report by PwC has highlighted the challenges faced by pharmaceutical companies if they are to succeed beyond 2020. -
News Global diabetes drugs market set for 9.7pc annual growth
TechNavio's latest report looks at the potential for growth in the diabetes drugs market. -
News DBT waiting for nod to set up 2 advanced institutes for research at cost of Rs.600 cr
The Department of Biotechnology (DBT) is planning to set up two advanced institutes for research including an Institute of Chronic Disease and Biotechnology. -
News Commerce minister's intervention sought to stop enforcing barcodes on pharma exports
The Medicines and Healthcare Products Agency (MHRA) is having consultations with the pharma industry and clinical research organisations (CROs) about the European Commissions proposal to have a new clinical trials regulation. -
News Definiens Appoints Dr. Gerald Möller as Chairman of its Supervisory Board
Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman. -
News US committee recommends approval of GSKs bird flu vaccine
A US health regulator has recommended the approval of GlaxoSmithKline's new bird flu vaccine. -
News World Diabetes Day: 14 November 2012
The European Medicines Agency supports World Diabetes Day, which is taking place on Wednesday 14 November 2012. -
News Sun Pharma to acquire DUSA Pharmaceuticals
Sun Pharma will acquire DUSA Pharmaceuticals in a deal worth approximately $230 million. -
News Boehringer Ingelheim to collaborate with Molecular Partners
Boehringer Ingelheim has entered into a manufacturing agreement with Molecular Partners -
News A completely new way of delivering anti-cancer drugs
A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incur... -
News Prostate cancer drug market 'worth $9.1bn by 2021'
Decision Resources' latest report looks at the prostate cancer drug market between now and 2021. -
News AMD and DR drug market to reach $6.25bn by 2015
There is a strong and growing market for drugs to treat the eye diseases AMD and DR, analysts say -
News Obama win keeps healthcare reforms at the forefront in US
Healthcare reforms will remain on the agenda in the US after Barrack Obama wins a second term as president. -
News Takeda to acquire Envoy Therapeutics
Takeda has announced the acquisition of Envoy Therapeutics for $140 million. -
News Claris Lifesciences announces joint venture in India and emerging markets
Claris, Otsuka Pharmaceutical and Mitsui have entered into a new joint venture. -
News WIN Consortium announces collaboration with Pfizer
The WIN Consortium has confirmed Pfizer as its first pharmaceutical partner. -
News Construction to begin on world's largest chromatography lab
Novasep intends to build the world's largest chromatography facility for pharmaceutical work. -
News Report recommends patient-centric approach to encourage adherence
Patient adherence to medication could be improved by adopting a more patient-centric approach, a report suggests. -
News UK spending on new medicines is falling
The head of the ABPI has expressed concern at the UK's falling expenditure on new medicines. -
News Watson sells Rugby OTC products and trademarks to Major Pharmaceuticals
Watson has sold its Rugby OTC product trademark and assets to the Harvard Drug Group. -
News Bayer set to buy Schiff Nutrition International for $1.2bn
Bayer has struck a deal to acquire US vitamin maker Schiff. -
News BioRx receives Zemaira distribution rights
BioRx has been added to the distribution network for Zemaira. -
News Celgene reports $1.4 billion of revenues for third quarter 2012
Celgene enjoyed healthy profits in the third quarter of 2012 -
News Sanofi to continue developing Prednisporin under sub-licencing agreement
Sanofi will continue development of Prednisporin, but expects to sub-licence the work to a third-party. -
News Organisational structure 'key to pharma compliance'
Pharmaceuticals have been told to centralise their compliance efforts for greater success. -
News Report reveals downward trend in US health R&D investment
There are concerns that the downward trend in R&D investment in the US could jeopardise the country's global competitiveness. -
News Charles River enters strategic partnership with AstraZeneca
Charles River Laboratories and AstraZeneca have reached a three-year agreement to deliver toxicology, safety pharmacology and development DMPK studies. -
News Forest and moksha8 form broad strategic alliance for Latin America
Forest Laboratories and moksha8 have announced a broad strategic alliance for Latin America. -
News Medicated chewing gum may prevent motion sickness
A team in Iran have produced a prototype gum with an acceptable taste that could help to deliver the motion sickness drug dimenhydrinate more rapidly. -
News 'Slight decline' in pharmaceutical M&A activity
A new report has highlighted a slight downward trend in mergers and acquisitions. -
News Global autologous cell therapy market worth $2.2bn by 2017
A number of autologous cell therapies are expected to reach the market by 2017, fuelling an impressive growth rate over the next few years. -
News Patent expiries 'pose challenge to enzyme inhibitor market growth'
A new TechNavio report has looked at the state of the global enzyme inhibitor market and its prospects for growth -
News Type-2 diabetes drug market set to double by 2021
The diabetes drug market is looking robust thanks to a large pipeline of new products and an ever-increasing patient population. -
News Australia may consider longer patent terms for medicines
The federal government in Australia has been urged to consider introducing longer patent terms for innovative medicines. -
News Capsugel ICSE/CPHI Booth #8F06
Expanded Finished Product Manufacturing Facilities Ready for Increased Licaps® Production -
News Medicia to distribute Injex 30 in Russia
A new distributor contract has been signed between Injex Pharma and Medicia. -
News New excipients on show at CPhl Worldwide in Madrid
New excipients will be on show at a pharmaceuticals event in Madrid later this month. -
News AMRI Announces Strategic Contract with Knopp Biosciences
SMARTSOURCING Agreement Strengthens Existing Relationship -
News BASF opens new topical formation lab in NY
BASF has announced the opening of a global dermatology lab in New York where topical formations will be developed for the pharmaceutical market. -
News Brazil delays new rules for governing excipients
Brazil's national medicines regulator has pushed back the implementation of proposed new rules that would govern the manufacturing of excipients. -
News PANREAC presents a new line of excipients for the pharmaceutical industry according to the IPEC guide
PANREAC specialized in the manufacturing of reagents for laboratory analysis, excipients and bulk chemicals to be used as raw materials in the pharmaceutical, cosmetic and food industries. -
News Panreac presents its synthesis product line
Panreac Synthesis is the business unit of PANREAC, the Spanish leader company in manufacturing reagents, solvents and fine chemicals since 1941. -
News Big pharma collaborate to speed up drug development
TransCelerate BioPharma is a non-profit organisation set up by ten biopharmaceutical giants. -
News Cardiolynx Receives Patent on Improved Angina Pectoris Drug
Cardiolynx Ltd., specializing in the development of improved cardio-metabolic therapies, announces that the European Patent Office (EPO) has granted a patent covering a new chemical entity, CLC-1280, developed using Cardiolynx' nitric oxide technology. -
News Mucosis Appoints Thomas Johnston to CEO
Mucosis B.V., the Dutch clinical-stage biotechnology company developing mucosal vaccines, today announced the appointment of Thomas Johnston to the position of Chief Executive Officer, effective immediately. -
News RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human)
The European Medicines Agency has been formally notified by RepliGen Europe Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine SecreFlo (secretin human). -
News Committee for Orphan Medicinal Products elects new chair and vice-chair
At its September 2012 meeting, the European Medicines Agency's Committee for Orphan Medicinal Products (COMP) elected Professor Bruno Sepodes from Portugal as its chair and Ms Lesley Greene, a volunteer patient representative for Eurordis, as its vice-... -
News European Medicines Agency clarifies rules on fees
The European Medicines Agency has revised the rules on fees payable to the Agency. -
News Stella Blackburn appointed president of the International Society for Pharmacoepidemiology
The European Medicines Agency congratulates Dr Stella Blackburn, the Agency's Risk Management Development and Scientific Lead, for her appointment as president of the International Society for Pharmacoepidemiology (ISPE). -
News Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair
The European Medicines Agencys recently established Pharmacovigilance Risk Assessment Committee (PRAC) has elected June Raine (pictured) from the United Kingdom (UK) as its chair and álmath Spooner from Ireland as its vice-chair at its second mee... -
News Big Pharma Fights Drug Rulings In India
Landmark drug patent protection cases involving Bayer, Roche, and Novartis are advancing in India this month. Together, they will help determine how friendly the country is to Western pharmaceutical makers. -
News AESICA ANNOUNCES KEY NORTH AMERICAN APPOINTMENT
One of Europes leading CMOs, Aesica, has announced a key addition to its commercial team as it looks to strengthen its position in North America. -
News Possible therapy for tamoxifen-resistant breast cancer identified
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. -
News Pfizer leukaemia drug receives US approval
The US Food and Drug Administration has approved Pfizer's Bosulif, used to treat a rare type of leukaemia usually suffered by older adults. -
News FDA questions efficacy of Novartis cystic fibrosis drug tobramycin
The US Food and Drug Administration has questioned the efficacy of Novartis' experimental cystic fibrosis drug tobramycin ahead of an advisory panel meeting this week. -
News Biotage Unveils New Fully Automated Microwave Peptide Synthesizer
Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, introduced an innovative new synthesis platform for peptide researchers at the 2012 European Peptide Symposium in Athens, Greece... -
News Majority of pharma firms have in-house companion diagnostics staff
Many companies now have people working full-time on companion diagnostics for use alongside targeted therapies. -
News Pfizer and Mylan announce generics collaboration in Japan
A new partnership between Pfizer and Mylan should help to drive generic utilisation in Japan. -
News Pharma companies spend over $30m on global MSL teams
Cutting Edge Information has shed light on pharmaceutical companies' MSL spend. -
News Peru's Pharmaceutical Exports to Exceed $50M in 2012
The president of Peru's pharmaceutical industry association has predicted that exports will surpass $50 million this year. -
News Generics Save Consumers Billions of Pounds
Consumers and national healthcare systems make significant savings as a result of generic medicines usage, a report has confirmed. -
News Saladax Expands Relationship with BMS
Saladax Biomedical has expanded its existing relationship with Bristol-Myers Squibb by entering into a Master Early Development Collaboration Agreement. -
News Gilead to Collaborate with Indian Partners on Generic Versions of Emtricitabine
Gilead and its partners in India aim to improve access to affordable antiretroviral therapy for HIV patients in developing countries. -
News Study Says Generic Medications Saved $1 Trillion over the Last Decade
The American health care system saved more than $1 trillion through the use of generic medicines over the last decade. -
News Patent Expirations Hit Irish Pharma Exports to US
The end of patent protection has hit Irish pharmaceutical exports to the US in the first half of the year, new figures show. -
News Suzhou Connect Enters Licensing Agreement with Arena
Suzhou Connect hopes to advance novel small molecule compounds for the treatment of allergic rhinitis and atopic dermatitis. -
News Merck Serono Announces Creation of Prexton
The newly founded company will develop the mGluR programs from lead optimization up to clinical Phase I and seek partnership and licensing opportunities for further development. -
News 'Organs-on-chips' to Accelerate Drug Candidate Assessment
Harvard scientists hope to develop a unique instrument that will help drug developers to assess new drug candidates.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance